SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer - Quaterly Results

15 May 2023 Evaluate
With no major difference for the quarter endedMarch 2023 , the total revenue stood at Rs. 5726.40  millions.Net profit showed a marginal rise at Rs. 1296.50 millions for the quarter ended March 2023, as compared to corresponding quarter of last year.The company reported a good operating profit of 2132.50 millions compared to 1825.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 5726.40 5496.60 4.18 24247.60 26109.90 -7.13 24247.60 26109.90 -7.13
Other Income 313.80 171.20 83.29 1010.50 626.50 61.29 1010.50 626.50 61.29
PBIDT 2132.50 1825.70 16.80 9099.10 8983.80 1.28 9099.10 8983.80 1.28
Interest 25.30 38.50 -34.29 133.90 104.90 27.65 133.90 104.90 27.65
PBDT 1911.30 1787.20 6.94 9295.20 8878.90 4.69 9295.20 8878.90 4.69
Depreciation 264.10 336.10 -21.42 1055.10 1150.00 -8.25 1055.10 1150.00 -8.25
PBT 1647.20 1451.10 13.51 8240.10 7728.90 6.61 8240.10 7728.90 6.61
TAX 350.70 193.20 81.52 2000.80 1603.30 24.79 2000.80 1603.30 24.79
Deferred Tax -315.30 -95.40 230.50 -519.10 -359.30 44.48 -519.10 -359.30 44.48
PAT 1296.50 1257.90 3.07 6239.30 6125.60 1.86 6239.30 6125.60 1.86
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 37.24 33.22 12.12 37.53 34.41 9.06 37.53 34.41 9.06

Pfizer Share Price

4815.00 3.95 (0.08%)
11-May-2026 09:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.00
Dr. Reddys Lab 1281.55
Cipla 1339.50
Zydus Lifesciences 932.80
Lupin 2282.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×